Stock listing

ASX:EPI Epiminder Ltd. Share Price

Home listing (ASX) of Epiminder Ltd.

Follow Epiminder Ltd. into a list and get an email when it puts out news.

Share price · ASX:EPI

$0.255 AUD -0.015 (-5.6%)

Close on Nov 20, 2026

This year -80.5% · daily closes, Dec 1, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.255 – $0.280 AUDNov 20, 2026
Volume
99,938 sharesNov 20, 2026
Market cap
$55.25M AUDAt the close on Nov 20, 2026 · price × 216.7M shares outstanding
Traded on an average day
$29,860 AUDMedian day 70,384 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Epiminder Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
ASX:EPI · Home$0.255 AUD-0.015 (-5.6%)99,938$0.280$0.280$0.255$0.270Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:EPI · AUD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.255-0.015-5.6%$0.280$0.280$0.25599,938
$0.2700.0000.0%$0.270$0.277$0.265162,872
$0.270-0.005-1.8%$0.285$0.290$0.27061,878
$0.2750.0000.0%$0.275$0.275$0.2750
$0.275+0.005+1.9%$0.265$0.280$0.265133,547
$0.270-0.010-3.6%$0.280$0.280$0.27072,710
$0.280-0.010-3.4%$0.290$0.290$0.28079,785
$0.290+0.035+13.7%$0.265$0.290$0.265236,906
$0.255-0.010-3.8%$0.265$0.265$0.25561,630
$0.265+0.025+10.4%$0.265$0.265$0.255371,182
$0.240-0.020-7.7%$0.265$0.270$0.24075,012
$0.260+0.005+2.0%$0.265$0.265$0.25529,826
$0.255+0.005+2.0%$0.250$0.255$0.25029,880
$0.250-0.015-5.7%$0.265$0.265$0.240130,923
$0.2650.0000.0%$0.265$0.265$0.26059,586
$0.265-0.005-1.9%$0.265$0.265$0.265688
$0.270+0.005+1.9%$0.270$0.280$0.265156,687
$0.265+0.010+3.9%$0.270$0.270$0.2657,887
$0.255-0.010-3.8%$0.255$0.255$0.25513,931
$0.265-0.005-1.9%$0.270$0.270$0.26531,930
$0.2700.0000.0%$0.270$0.270$0.27042,543
$0.270-0.012-4.4%$0.275$0.275$0.27015,500
$0.283+0.012+4.6%$0.275$0.283$0.27522,659
$0.270-0.015-5.3%$0.290$0.290$0.27017,935
$0.2850.0000.0%$0.290$0.290$0.28066,620
$0.285+0.005+1.8%$0.280$0.290$0.270201,620
$0.280-0.005-1.8%$0.280$0.280$0.2805,587
$0.2850.0000.0%$0.295$0.295$0.280122,298
$0.285-0.010-3.4%$0.295$0.295$0.28551,988
$0.2950.0000.0%$0.295$0.295$0.29057,309
$0.2950.0000.0%$0.295$0.295$0.29013,946
$0.295+0.025+9.3%$0.320$0.330$0.29070,227
$0.270+0.005+1.9%$0.260$0.270$0.26099,913
$0.265+0.005+1.9%$0.260$0.265$0.26028,459
$0.260-0.005-1.9%$0.260$0.260$0.25866,063
$0.265+0.005+1.9%$0.263$0.265$0.26060,946
$0.2600.0000.0%$0.250$0.260$0.25070,540
$0.260-0.015-5.5%$0.270$0.270$0.250111,067
$0.275-0.015-5.2%$0.290$0.295$0.27052,523
$0.290+0.010+3.6%$0.290$0.290$0.29071,287
$0.280+0.015+5.7%$0.270$0.285$0.270213,975
$0.265+0.015+6.0%$0.265$0.270$0.250140,821
$0.250-0.030-10.7%$0.280$0.280$0.250569,151
$0.280-0.010-3.4%$0.290$0.290$0.280127,763
$0.2900.0000.0%$0.295$0.295$0.29026,705
$0.290+0.005+1.8%$0.290$0.300$0.285186,896
$0.285+0.005+1.8%$0.285$0.285$0.28540,526
$0.280-0.020-6.7%$0.300$0.300$0.280130,417
$0.3000.0000.0%$0.308$0.308$0.30065,633
$0.300-0.005-1.6%$0.305$0.305$0.30048,365
$0.305-0.005-1.6%$0.315$0.315$0.30042,512
$0.310-0.005-1.6%$0.310$0.355$0.310138,246
$0.315+0.003+0.8%$0.320$0.320$0.31559,389
$0.313-0.008-2.3%$0.330$0.330$0.305129,948
$0.3200.0000.0%$0.330$0.330$0.315243,708
$0.320-0.005-1.5%$0.325$0.340$0.320121,598
$0.325-0.025-7.1%$0.350$0.350$0.300222,496
$0.350+0.010+2.9%$0.360$0.360$0.335116,815
$0.340-0.010-2.9%$0.360$0.360$0.34020,138
$0.350-0.015-4.1%$0.365$0.365$0.35035,424
$0.365+0.005+1.4%$0.350$0.365$0.34819,275
$0.360-0.045-11.1%$0.405$0.405$0.340237,694
$0.4050.0000.0%$0.400$0.415$0.40075,915
$0.405-0.055-12.0%$0.450$0.450$0.400305,841
$0.4600.0000.0%$0.465$0.470$0.45596,978
$0.460+0.020+4.5%$0.460$0.465$0.445135,456
Ticker
ASX:EPI
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
ASX
Currency
AUD

What changed lately

Latest news

Change of Address Update

Nov 12, 2026

Closed $0.275 (+1.9%) on Nov 13, 2026

Resignation of Chief Financial Officer

Nov 3, 2026

Closed $0.26 (+2.0%) on Nov 4, 2026

Change of Address

Nov 2, 2026

Closed $0.255 (+2.0%) on Nov 3, 2026

Results of Annual General Meeting

Oct 29, 2026

Closed $0.265 (0.0%) on Oct 30, 2026

All Epiminder Ltd. news

Epiminder Ltd. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
35 in the last 12 months · 35 in all · newest Nov 16, 2026 · oldest 2025
Decks
3 decks · latest Oct 30, 2026

Where Epiminder Ltd. is listed

ListingExchangeCountryCurrency
ASX:EPI · Home listing · This pageASXAustraliaAUD
Dusseldorf:1L7DusseldorfGermanyEUR
Frankfurt:1L7FrankfurtGermanyEUR

Valuation

Price/book 0.7× against a median of 1.3×: 3rd lowest of 9 Medical devices & supplies companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
−$20.54M AUD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.7×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Epiminder Ltd. · ASX:EPIUS$36.57M−US$13.60Mn/an/an/a0.7×n/a0.0×n/a
electroCore, Inc. · NASDAQ:ECORUS$40.78MUS$41.51Mn/a1.1×n/an/a−33.5%n/a1.91
Elutia, Inc. · NASDAQ:ELUTUS$39.86MUS$18.87M0.7×1.5×n/a2.6×441.2%0.5×-0.06
DRGEM Corp. · KRX:263690US$38.81MUS$32.33M4.3×0.4×3.2×0.5×11.2%0.1×n/a
Cryofocus Medtech (Shanghai) Co. Ltd. Class H · HKEX:6922US$37.93MUS$29.03Mn/a2.0×n/a3.8×−40.1%0.0×n/a
Ocumetics Technology Corp · TSXV:OTCUS$37.38MUS$37.60Mn/an/an/an/an/an/a0.14
Optomed Oyj Class A · OMXHEX:OPTOMEDUS$37.24MUS$32.48Mn/a1.8×n/a1.6×−33.9%0.1×n/a
Sensus Healthcare, Inc. · NASDAQ:SRTSUS$37.20MUS$24.56Mn/a1.5×n/a1.1×−96.5%0.0×1.08
Avita Corporation · TPEX:4735US$35.63MUS$14.80M5.1×0.5×4.4×1.0×23.8%0.0×n/a
SELVAS Healthcare, Inc. · KRX:208370US$35.56MUS$15.07M5.5×0.6×8.0×0.6×27.5%0.0×n/a
Taiwan Biomaterial Co., Ltd. · TPEX:6649US$35.55MUS$28.06M35.3×5.1×26.5×1.8×18.2%0.0×n/a
Median of the othersUS$37.31MUS$28.55M5.1×1.5×6.2×1.3×11.2%0.0×0.61

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
2.22 AUD · Analysts' mean
EPS, year to Jun 2027
-0.20 · 1 analyst

Team and board

Officers

OfficerRole
Rohan HoareChief Executive Officer & Managing Director
John HeasmanChief Operating Officer
Chip MoebusVP, Market Access
Melita LambirisVP, Quality & Regulatory
Steven RingoVP, IT & Security
Tracy CameronVP, Clinical & Regulatory
Mark CookChief Medical Officer
Toby McSweeneyChief Technology Officer

Board

DirectorRole
Philip BinnsChair
Donal O'DwyerIndependent Non-Executive Director
Jeff SellsIndependent Non-Executive Director
Patricia O'RourkeNon-Executive Director
Robert KlupacsNon-Executive Director

Decks

DeckKindSlidesDate
Shareholder Meeting (October 2026)Shareholder meeting30 slidesOct 30, 2026
Investor Presentation (July 2026)Investor deck29 slidesJul 30, 2026
H1 FY2026 Earnings PresentationEarnings20 slidesFeb 25, 2026

Open Decks

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023
Revenue445.2K6.56M5.49M
Cost of revenue4.00M
Gross profit-4.00M
Research and development17.2M
Selling, general and administrative16.1M14.4M9.36M7.42M
Operating income-43.6M-29.8M-14.1M-15.1M
Depreciation and amortization39.0K68.0K92.0K82.8K
EBITDA-43.6M-29.8M-14.0M-15.1M
Interest expense1.22M3.04M1.95M1.01M
Income before tax-42.7M-31.8M-15.9M-16.1M
Net income-42.7M-31.8M-15.9M-16.1M
Earnings per share, basic-0.20-0.18-0.07-0.07

Balance sheet

LineFY2026FY2025FY2024FY2023
Cash and equivalents75.8M117.0M11.3M11.2M
Receivables383.3K5.91M8.30M
Current assets77.6M117.5M17.6M20.0M
Property, plant and equipment70.6K62.5K28.7K
Total assets90.8M130.7M34.2M36.6M
Accounts payable1.85M22.6M
Current liabilities7.97M23.2M5.90M8.81M
Long-term debt48.0M36.0M26.3M
Total liabilities9.17M23.3M42.0M35.2M
Shareholders' equity81.7M107.4M-7.79M1.39M
Shares outstanding216.7M175.2M216.7M216.7M

Cash flow

LineFY2026FY2025FY2024FY2023
Cash from operations-17.0M-13.8M-14.2M
Capital spending0-38.1K-49.8K-25.1K
Free cash flow-17.0M-13.8M-14.3M
Cash from investing-38.1K-49.8K-25.1K
Cash from financing110.0M14.6M14.0M10.4M
Share buybacks-9.56M05.54M0
Change in cash66.7M-2.46M140.2K-3.92M

Open Financials

Filings

FilingDateTypeFiled with
Strategic partnership with leading US EEG providerNov 16, 2026Operations updateASX
Change of Address UpdateNov 12, 2026Other filingsASX
CMS Increases Medicare Payment for the Minder System CY 2027Nov 5, 2026GuidanceASX
Resignation of Chief Financial OfficerNov 3, 2026Management or board changeASX
Change of AddressNov 2, 2026Other filingsASX
Results of Annual General MeetingOct 29, 2026Meeting outcomeASX
Minder System Cleared for Patients 12 -75 Years of AgeOct 29, 2026Operations updateASX
Minder System Cleared for Patients 12 -75 Years of AgeOct 29, 2026Operations updateASX
FY27 YTD operational update and AGM materialsOct 29, 2026Operations updateASX
FY27 YTD operational update and AGM materialsOct 29, 2026Operations updateASX
All 34 filings
FilingDateTypeFiled with
Quarterly Activities/Appendix 4C Cash Flow ReportOct 27, 2026Quarterly reportASX
Quarterly Activities/Appendix 4C Cash Flow ReportOct 27, 2026Quarterly reportASX
100th patient enrolled in US study ahead of scheduleOct 14, 2026Operations updateASX
Updated Securities Trading PolicyOct 2, 2026Other filingsASX
Change of Director's Interest Notice DOOct 1, 2026Ownership change noticeASX
Notice of Annual General Meeting/Proxy FormSep 29, 2026Meeting noticeASX
75th DETECT EnrolleeSep 16, 2026Other filingsASX
Change of Director's Interest Notice PBSep 3, 2026Ownership change noticeASX
Change of Director's Interest Notice DOSep 2, 2026Ownership change noticeASX
FY26 Appendix 4G and Corporate Governance StatementAug 25, 2026Other filingsASX
FY26 Appendix 4E and Annual ReportAug 25, 2026Annual reportASX
Change of Director's Interest Notice JSAug 19, 2026Ownership change noticeASX
Change of Director's Interest Notice DOAug 17, 2026Ownership change noticeASX
Change of Director's Interest Notice RKAug 11, 2026Ownership change noticeASX
FY26 Investor PresentationJul 29, 2026Other filingsASX
Quarterly Activities/Appendix 4C Cash Flow ReportJul 29, 2026Quarterly reportASX
Trading UpdateJul 15, 2026Operations updateASX
DETECT Study reaches 25th enrolment as momentum buildsMay 31, 2026Other filingsASX
1H FY26 Results PresentationFeb 24, 2026Interim reportASX
1H FY26 Results AnnouncementFeb 24, 2026Interim reportASX
1HFY26 Appendix 4D and Financial ReportFeb 24, 2026Interim reportASX
Quarterly Activities/Appendix 4C Cash Flow ReportJan 27, 2026Quarterly reportASX
First Implant of Minder System in the USJan 18, 2026Operations updateASX
Finalisation of historical R&D tax claimsDec 16, 2025Other filingsASX

Open Filings

Cap table

Built by 6ix from Epiminder Ltd.’s releases

Common shares
216,671,652
Fully diluted
216,671,652

Fully diluted

LineShares
Common shares216,671,652

Share count over time

CountShares
Nov 22, 2026216,671,652

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chip MoebusVP, Market Access · Since at least Nov 4, 2026
Donal O'DwyerIndependent Non-Executive Director · Since at least Nov 5, 2026
Jeff SellsIndependent Non-Executive Director · Since at least Nov 4, 2026
John HeasmanChief Operating Officer · Since at least Nov 4, 2026
Mark CookChief Medical Officer · Since at least Nov 4, 2026
Mark McLellanChief Financial Officer and Company Secretary · Nov 3, 2026 – Nov 3, 2026 · Past
Melita LambirisVP, Quality & Regulatory · Since at least Nov 4, 2026
Patricia O'RourkeNon-Executive Director · Since at least Nov 5, 2026
Philip BinnsChair · Since at least Nov 4, 2026
Robert KlupacsNon-Executive Director · Since at least Nov 5, 2026
All 14 people
PersonSeat
Rohan HoareChief Executive Officer & Managing Director · Since at least Nov 5, 2026
Steven RingoVP, IT & Security · Since at least Nov 4, 2026
Toby McSweeneyChief Technology Officer · Since at least Nov 4, 2026
Tracy CameronVP, Clinical & Regulatory · Since at least Nov 4, 2026

Open People

Log in to ask 6ix AI your own questions about Epiminder Ltd.